- Remark Holdings Inc's share is set to extend its gains on Thursday.
- Demand for thermal imaging kit is rising as states aim to reopen the economies securely.
- NASDAQ: Mark may prove a counter-cyclical stock.
The coronavirus pandemic has mostly losers and some winners. Remark Holdings inc. could enjoy a win-win situation – at least until a vaccine is fully administered to the public. The Las Vegas-based company makes thermal imaging equipment that scans people's body temperatures on the fly in a seamless fashion.
The technology is already deployed in some places in Nevada and facilitates controlling of people coming in for COVID-19 tests. It saves time in comparison to other means of catching those who have a fever.
Broader stock markets are on the rise and one of the reasons is the improvement in illness indicators. While the US surpassed the grim milestone of 100,000 deaths, the daily mortality rate has slipped to around 1,000, half the peak in early April. This comes alongside a gradual reopening of the economy.
Remark Holdings' stock is already beating gains in the S&P 500 – a win in good times.
However, the national figures mask a mixed reality. While coronavirus infections and losses of life are declining in the greater New York area and several other hotspots, it remains prevalent and even increasing in other states. That may cause a nationwide plateau rather than an ongoing decrease.
For MARK, it would mean more demand to control potential flareups and the stock could rise while the main stock indexes decline. Moreover, cases rise and peak in different places at different times – allowing a smoother production and distribution of the thermal imaging kit, without bottlenecks.
That means the stock is a win also in bad times.
Mark stock news
NASDAQ:MARK rose by over 18% on Wednesday to close at $3.40. It is marginally declining by $0.07 in pre-market trading. That may be a necessary correction after a seven-fold multiplication in value since early May.
From the 52-week low, Remark is up by over 1.300%. It may be time for a pause before the next leg up.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD turns sideways below 1.0900 ahead of Fedspeak
EUR/USD is trading sideways below 1.0900 in European trading on Monday, despite a risk-on market mood. The pair, however, finds support from the struggling US Dollar and sluggish US Treasury bond yields, awaiting Fedspeak amid light European trading.
Gold price consolidates near $2,450, fresh record highs
Gold price holds its upbeat momentum intact on Monday, sitting at fresh record highs of $2,450 in the European session. The bright metal benefits from renewed hopes for Fed rate cuts and renewed geopolitical tensions surrounding Iran. Fedspeak is next on tap.
GBP/USD holds steady near 1.2700, Fedspeak in focus
GBP/USD is off the highs, consolidating near 1.2700 in the European trading hours on Monday. A subdued US Dollar supports the pair amid moderate risk appetite. Traders stay cautious on potential geopolitical escalation in Iran and ahead of Fedspeak.
Ripple stays above $0.50 on Monday as firm backs research on blockchain and quantum computing
XRP price holds steady above the $0.50 key support level and edges higher on Monday, trading at 0.5130 and rising 0.70% in the day at the time of writing.
Week ahead: Nvidia results and UK CPI falling back to target
What a week for investors. The Dow Jones reached a record high and closed last week above 40,000, for the first time ever. This is a major bullish signal even though gains for global stocks were fairly modest on Friday, and European stocks closed lower.